Other Viruses Citation List:
March 18 - March 31, 2011
Herpes simplex virus
1. In Vitro Evaluation of Antiviral and Virucidal Activity of a High Molecular Weight Hyaluronic Acid. Cermelli, C., A. Cuoghi, M. Scuri, C. Bettua, R.G. Neglia, A. Ardizzoni, E. Blasi, T. Iannitti, and B. Palmieri. Virology Journal, 2011. 8(1): p. 141; PMID[21439070].
[Pubmed]. OV_0318-033111.
Hepatitis C virus
2. The Inhibitory Effect on Hepatitis C Virus Infection of a Triterpenoid Compound, with or without Interferon-Alpha. Watanabe, T., N. Sakamoto, M. Nakagawa, S. Kakinuma, Y. Itsui, Y. Nishimura-Sakurai, M. Ueyama, Y. Funaoka, A. Kitazume, S. Nitta, K. Kiyohashi, M. Murakawa, S. Azuma, K. Tsuchiya, S. Oooka, and M. Watanabe. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21444704].
[Pubmed]. OV_0318-033111.
3. Investigation of the Mode of Binding of a Novel Series of N-Benzyl-4-Heteroaryl-1-(Phenylsulfonyl)Piperazine-2-Carboxamides to the Hepatitis C Virus Polymerase. Gentles, R.G., S. Sheriff, B.R. Beno, C. Wan, K. Kish, M. Ding, X. Zheng, L. Chupak, M.A. Poss, M.R. Witmer, P. Morin, Y.K. Wang, K. Rigat, J. Lemm, S. Voss, M. Liu, L. Pelosi, S.B. Roberts, M. Gao, and J.F. Kadow. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21441029].
[Pubmed]. OV_0318-033111.
4. Potent Inhibitors of Hepatitis C Core Dimerization as New Leads for Anti-Hepatitis C Agents. Ni, F., S. Kota, V. Takahashi, A.D. Strosberg, and J.K. Snyder. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21440437].
[Pubmed]. OV_0318-033111.
5. Inhibition of Hepatitis C Virus Replication by Herbal Extract: Phyllanthus Amarus as Potent Natural Source. Ravikumar, Y.S., U. Ray, M. Nandhitha, A. Perween, H.R. Naika, N. Khanna, and S. Das. Virus Research, 2011. [Epub ahead of print]; PMID[21440018].
[Pubmed]. OV_0318-033111.
6. Inhibition of Hepatitis C Virus Replication by Semi-Synthetic Derivatives of Glycopeptide Antibiotics. Obeid, S., S.S. Printsevskaya, E.N. Olsufyeva, K. Dallmeier, D. Durantel, F. Zoulim, M.N. Preobrazhenskaya, J. Neyts, and J. Paeshuyse. The Journal of antimicrobial chemotherapy, 2011. [Epub ahead of print]; PMID[21436155].
[Pubmed]. OV_0318-033111.
7. Broad-Spectrum Antiviral That Interferes with De Novo Pyrimidine Biosynthesis. Hoffmann, H.H., A. Kunz, V.A. Simon, P. Palese, and M.L. Shaw. Proceedings of the National Academy of Sciences of the United States of America, 2011. [Epub ahead of print]; PMID[21436031].
[Pubmed]. OV_0318-033111.
8. Antiviral Stilbene 1,2-Diamines Prevent Initiation of Hepatitis C Viral Rna Replication at the Outset of Infection. Gastaminza, P., S.M. Pitram, M. Dreux, L.B. Krasnova, C. Whitten-Bauer, J. Dong, J. Chung, V.V. Fokin, K.B. Sharpless, and F.V. Chisari. Journal of Virology, 2011. [Epub ahead of print]; PMID[21430055].
[Pubmed]. OV_0318-033111.
9. The Effect of the P1 Side Chain on the Binding of Optimized Carboxylate and Activated Carbonyl Inhibitors of the Hepatitis C Virus Ns3 Protease. Kawai, S.H., S.R. Laplante, M. Llinas-Brunet, and O. Hucke. Future Medicinal Chemistry, 2010. 2(7): p. 1073-1081; PMID[21426157].
[Pubmed]. OV_0318-033111.
10. 2,3-Dihydro-1,2-Diphenyl-Substituted 4h-Pyridinone Derivatives as New Anti Flaviviridae Inhibitors. Peduto, A., A. Massa, A. Di Mola, P. de Caprariis, P. La Colla, R. Loddo, S. Altamura, G. Maga, and R. Filosa. Chemical Biology & Drug Design, 2011. [Epub ahead of print]; PMID[21414145].
[Pubmed]. OV_0318-033111.
Citations from the ISI Web of Knowledge Listings for O.V.
11. Synthesis and Anti-Hepatitis B Virus Activity of Acyclovir Conjugated Stearic Acid-G-Chitosan Oligosaccharide Micelle. Huang, S.T., Y.Z. Du, H. Yuan, X.G. Zhang, J. Miao, F.D. Cui, and F.Q. Hu. Carbohydrate Polymers, 2011. 83(4): p. 1715-1722; PMID[ISI:000286965400039].
[WOS]. OV_0318-033111.
12. Host Sphingolipid Biosynthesis Is a Promising Therapeutic Target for the Inhibition of Hepatitis B Virus Replication. Tatematsu, K., Y. Tanaka, M. Sugiyama, M. Sudoh, and M. Mizokami. Journal of Medical Virology, 2011. 83(4): p. 587-593; PMID[ISI:000287570400004].
[WOS]. OV_0318-033111.